It is now recognized that human whole blood, plasma, or serum may occasionally contain an agent, or agents, capable of producing hepatocellular jaundice when administered parenterally to susceptible persons (1 to 4). Thus far, the only method of detecting the presence of this agent in such materials is by testing them in human volunteers. The present studies in human volunteers, which were initiated by the occurrence of jaundice in a case previously de- (4) . A few cases of jaundice had occurred among the patients of this institution during the year before this study was begun, but no case was subse- quently observed, among the hospital population of approximately 6000 patients and 590 employees, until after the experimentally induced disease had appeared in the volunteer group, when 2 of the employees developed jaundice (see below). One of the volunteers (H. J. C.) had a history of jaundice 4 years prior to this study, but the other 8 had no history of jaundice. Several had attended patients with jaundice during the preceding year. The volunteers were observed for 1 to 3 weeks before inoculation and none showed evidence of hepatic dysfunction during this period.
Procedure. After obtaining a specimen of plasma for preservation in the frozen state, the volunteers were inoculated with one of several suspected materials in order to determine the presence of an icterogenic agent. They were then studied, at frequent intervals, by means of a group of liver function tests so as to detect the earliest evidence of hepatic disturbance. As soon as this appeared, the men were hospitalized.4 Plasma or serum, stools, bile, nasopharyngeal washings, and urine, to be used in future experiments, were collected during the pre-icteric and icteric stages.
The materials used for inoculation were as follotvs:
1. Plasma A-pooled convalescent mumps plasma, obtained in April 1942 from a group of 14 soldiers of the U. S. Army, stationed in this country, during their convalescence from mumps. The blood was collected in bottles containing sodium citrate as an anticoagulant; the plasma was removed, cultured, and frozen. The routine cultures were negative. In June 1942, a civilian with mumps was treated with this plasma and 76 days later developed jaundice (3) . The plasma was considered responsible for transmission of the icterogenic agent and was withheld from further usage. When used in this study, it had been preserved in the frozen state for approximately 18 months. Previous studies had shown that this material was not icterogenic for a large number of animals (5, 6) . 2 . Plasma B-obtained from volunteer B. C. during mild hepatitis, 23 days after his inoculation with plasma A. The blood was collected in a bottle containing sodium citrate as an anticoagulant; the plasma was removed, cultured, and frozen. The cultures were negative. The plasma was used in this study 1 ' Recent studies have shown that discrepancies obtained in the results of tests set up in 2 different laboratories are due, in large part, to variation in the amount of light to which the serum-antigen mixtures are exposed. When kept in the dark or in subdued light, the results are more uniform and fewer false positives are obtained (Science, 1944, 100, 83) . the biuret photoelectric method of Kingsley (12) . The preinoculation range for this group was: Total protein 6.9 to 8.2; albumin 5.0 to 6.0; globulin 1.6 to 2.6 grams per 100 ml. Total and esterified serum cholesterol levels were estimated by the method of Reinhold (13) and the range was: Total-158 to 286 mgm. per 100 ml., esters-95 to 161 mgm. per 100 ml., or 50 to 76 per cent of the total. Serum alkaline phosphatase was measured by the method of Bodansky adapted to the photoelectric colorimeter (14) . The range before inoculation was from 1.5 to 3.4 Bodansky units. Prothrombin activity was determined by the method of Quick (15) . Before inoculation it varied between 70 and 100 per cent of normal. Vitamin A7 was estimated in blood plasma by the method of Kimble (16) which is based on the Carr-Price reaction. The results have been expressed in International Units, calculated according to Kimble's directions. Facilities for this determination were not available at the beginning of the investigation, so that preinoculation levels could not be established. However, estimations were made in several cases before the onset of hepatitis and these results probably approach the preinoculation level. Sedimentation rates were determined by the Wintrobe technic (17) . The range before inoculation was from 3 to 15 mm. per hour. Erythrocyte fragility was measured by the method of Waugh and Asherman (18) . The procedure proved to be satisfactory, but the solutions were found to change in pH on standing, so that considerable time and effort were expended on the necessarily frequent checks of the reagents. Routine blood counts were performed periodically throughout the study. "Target" cells . (19) (23) was used at less frequent intervals because of difficulties in the collection of the required 24-hour urine specimens. Bile acids were sought by the method of Hay (24) . It was realized that a negative test did not exclude the presence of bile acids. Routine urinalyses were performed periodically throughout the investigation. The intravenous hippuric acid test was performed according to the technic recommended by Quick (15 of the volunteers. However, several of the controls were studied at frequent intervals over periods of 4 to 10 weeks.
RESULTS
Incidence of hepatitis. The incidence of hepatitis following the inoculation of 9 human volunteers is shown in Table I . To the first group of Course of disease. The course of the disease in each of the volunteers is portrayed by the data charted in Figures 1 to 9 . Mild symptoms and signs, usually occurring from 12 to 35 days after inoculation, marked the onset of the disease. This was followed by an asymptomatic interval or by periodic recurrences of mild symptoms and signs which, after 73 to 110 days, usually culminated in the familiar clinical picture of an acute hepatitis with jaundice. The course thereafter was similar to that observed in mild infective hepatitis." For this reason, the main interest has centered about the long interval between inoculation and jaundice. As no evidence of hepatic dysfunction was detected in any of, the volunteers prior to inoculation, abnormal results with more than one liver function test have been regarded as an indication of'hepatic disturbance due to the inoculation. In this report, such a disturbance is referred to as hepatitis, since studies have shown that the pathologic picture, at least during the icteric stage, is that of hepatitis (27, 28) . When interpreted on this basis, the charts show that hepatitis was present long before it was manifested by jaundice. In some cases, the process seemed to be active continuously during the interval between the onset of the disease and the development of jaundice, whereas in others, it appeared to be active intermittently. For purposes of discussion, it has been convenient to consider the course of the disease in 2 periods; an early period, which includes the first 60 days after inoculation, and a late period, which covers the interval beyond 60 days. Based on this arbitrary division, Table II shows the time of onset, in each volunteer, of the early and late manifestations of hepatitis. From these data, it is seen that the onset occurred during the first 11 The term infective hepatitis is used here to include both the sporadic and the epidemic types of infective hepatitis. So-called sporadic and epidemic catarrhal jaundice, epidemic hepatitis, and infectious hepatitis or jaundice are other terms which are used in the literature more or less synonymously with infective hepatitis. (Figure 10 ), the several preinoculation determinations have been of great value in the interpretation of the significance of small changes. The tests for serum bilirubin concentration, bilirubinuria, cephalin flocculation, bromsulphalein excretion, plasma vitamin A, and prothrombin activity were found to detect hepatic disturbance more consistently and promptly than did the tests for urine urobilinogen, total serum protein, albumin and globulin concentrations, total and esterified cholesterol, serum alkaline phosphatase, hippuric acid excretion and sedimentation rate. The results of all these tests have been included in Figure 1 because the case history is presented in this report, and also because this subject was the source of Plasma B. Figures 2  to 9 , however, include only those tests which provided the most pertinent information. Figure  10 shows the results of the studies on a normal individual over a period of 60 days.
It will be noted that bilirubinuria was among the first signs of hepatic disturbance (Figures 2,  3, 6, 9) . Moreover, it sometimes appeared long before there was any significant increase in the 2, 3, 9 ). In 1 case (Figure 9) (Figures 3, 4) . In only 1 case (Figure 1) (Figures 2, 3, 8, 9) , and was usually one of the last to return to normal (Figures 2, 3, 4, 8, 9 ), thus affording one of the best indices of recovery. (Figure 1 ), urine urobilinogen (W. D. S.; B. C., Figure 1 ), and sedimentation rate (N. H. H., J. C.) added support to the evidence of hepatic dysfunction when the significance of changes in the results of other procedures was uncertain. It is apparent that no single test provides reliable information concerning-the hepatic func-tional state at all times. A group of tests is therefore necessary, if mild hepatic disturbance is to be detected, and for this type of liver disease, the tests for serum bilirubin concentration, bilirubinuria, cephalin flocculation, bromsulphalein retention, plasma vitamin A level, and prothrombin activity appear to be the most satisfactory.
The studies on the control group indicated that the tests for serum bilirubin, urine bilirubin, cephalin flocculation, plasma vitamin A, cholesterol esters, prothrombin activity, and sedimentation rate occasionally yielded abnormal results in normal persons (Figure 10 ) or during incidental minor illnesses, unrelated to hepatitis. However, such abnormalities were never found with more than one of these tests at the same time. One person had repeated studies during a 10-day gastrointestinal upset in which the symptoms were similar to those observed in the volunteer group in association with mild hepatitis. In this case, all the tests were repeatedly negative. On the basis of these observations, it has seemed justifiable to regard abnormal results with more than one liver function test as evidence of hepatic disturbance, presumably due, in these cases, to hepatitis.
CASE REPORT
A brief summary of the case of B. C. has been included to illustrate the varied phenomena that may be associated with this disease. B. C. (Figure 1 ), age 22, after the control studies, was inoculated intravenously with 1.0 ml. of Plasma A. Twentytwo days after inoculation he developed generalized aches and pains, headache, marked anorexia, nausea, vomiting, weakness, malaise, and elevation of temperature to 102°F. Examination revealed tendern,ess to fist percussion over the liver and a palpable spleen. Laboratory studies revealed an elevated serum bilirubin, retention of bromsulphalein, and increased urobilinogen in the urine. A number of "target cells" were observed in the blood smear. Plasma B was obtained from him on the 23rd day. Prompt recovery ensued and he was well until the 55th day when anorexia returned, and was associated with vomiting and loose stools. The cephalin cholesterol test was weakly positive (1+). From the 60th to 76th day, the eruption described previously appeared on the forearms. From the 72nd to 80th day, malaise, anorexia, and sore throat were noted. The serum bilirubin rose on the 77th day (Figure 1 ), but promptly returned to normal.
On the 85th day, nausea, slight diarrhea, and vague persistent discomfort in the right lower abdomen occurred in association with focal tenderness in the nrght lower quadrant. The leukocyte count was 10,400 and temperature was 99.4°F. The surgeon advised laparotomy because of possible appendicitis. At operation, the appendix was normal, but the lower ileum was diffusely inflamed and the mesentery edematous and studded with swollen, enlarged lymph nodes. Post-operative roentgen examination of the gastrointestinal tract revealed no abnormality.
On the 109th day, malaise, anorexia, nausea, and dark urine appeared, and were followed, on the 110th day, by jaundice. On the 114th day, he developed urticaria after injection of bromsulphalein. While still jaundiced, 118 to 123 days after inoculation, there was slight elevation of temperature and a moderately severe diarrhea. On the 126th day, roentgen examination of the gastrointestinal tract revealed an abnormal ileal pattern similar to that of regional ileitis, but the symptoms, by this time, had disappeared.
He was well after his discharge from the hospital on the 129th day, and roentgen examination of the gastrointestinal tract on the 213th day showed marked improvement of the small intestinal pattern, although slight abnormality still persisted. On the 232nd day, he was in good health, but the cephalin test was still intermittently positive.
This case illustrates the occurrence of repeated manifestations of this disease before the development of jaundice. The demonstration of an acute ileitis and mesenteric adenitis at laparotomy is interesting in view of the post-mortem findings in the fatal cases of post-vaccinal hepatitis that occurred in the U. S. Army (1942) . In these cases, acute inflammation and edema of various parts of the gastrointestinal tract were frequently observed (27 (102°F.) during the prodromal stage, and in this respect, their disease differed from that of the volunteers, in whom only slight elevations were observed. The absence of other contact cases among the large institutional group, and especially among the 87 men with whom the volunteers were quartered, indicated that there was little tendency for the experimentally produced disease to spread by ordinary contact. Because of the exposure of these 2 persons to the experimentally produced disease, and theabsence of recognized exposure to other jaundiced patients or to each other, infection acquired from the volunteer remains a possibility. Propert (36) has previously recorded 2 cases of jaundice in which the infection appeared about 2 months after exposure to patients with measles serum hepatitis.
DISCUSSION
The fact that homologous blood products may contain an agent capable of producing hepatitis has been confirmed by the results of the inoculation of this group of men with plasma or yellow fever vaccine containing human serum. The high incidence (100 per cent) in this series is of interest in comparison with that reported by other investigators. Propert (36) studies, may easily be overlooked. Also, in connection with the significance of the high incidence in the present group, it seems advisable to emphasize the apparent absence of other cases of jaundice among the large instutional group, with the exception of 2 cases that appeared after the disease had developed in the experimental group.
By the use of liver function tests, it has been ascertained that the onset of hepatitis, produced by an agent in serum, may be much earlier than has been generally recognized, a fact which may necessitate a revision of the current estimates of the incubation period of this disease. In 7 of the 9 volunteers, the incubation period, measured from the time of inoculation to the first manifestations of hepatitis, was 12 to 50 days, and in 6 of these, it was between 12 and 35 days. It thus appears that overt jaundice is probably a late manifestation of this malady, and one which, as indicated by 3 of the present cases, may not appear at all. The shorter incubation period directly concerns the relation of this disease to infective hepatitis. The possible etiologic identity of these diseases has been discussed repeatedly (33, 37, 38) but no conclusions have yet been reached. In this regard, the 2 alleged forms of infective hepatitis must be briefly mentioned. (a) Single sporadic cases occurring without apparent contact with other cases of jaundice are frequently seen, and they, in turn, often do not seem to infect others with whom they are in close contact. This type of the disease apparently has little tendency to spread. However, this or a similar disease occasionally occurs in, (b) a distinctly epidemic form. It is not yet known whether these 2 types are caused by the same or different agents. The same problem exists in connection with the relationship of the causative agent or agents of these types of hepatitis to that which is transmitted by serum. An apparently shorter incubation period, the more frequent occurrence of fever, and the contagious nature have been cited as features of the epidemic type of hepatitis that suggest a difference between its causative agent and that of serum jaundice (2, 37, 38) . It has been indicated by the present study that the periods of incubation may coincide. The occurrence of fever is a questionable means of distinction, for it may be present in some cases transmitted by serum and absent in some cases of infective hepatitis unrelated to serum. Furthermore, minor differences in the clinical manifestatiops of serum hepatitis might exist because of (a) the differences in the portal of entry of the agent (37, 38) , (b) the conditions under which the agent or agents have existed prior to entry, such as desiccation, and (c) the possible presence of immune bodies in "hepatitis-producing" serum or plasma pools that might be temporarily protective. Thus, the length of the incubation period, the clinical phenomena, and the pathologic changes (27, 28) do not appear to provide a satisfactory basis for distinguishing between the etiological agents of these diseases. The tendency of the epidemic type of hepatitis to spread among contacts, therefore, seems to be the chief remaining point of distinction. There is as yet no unequivocal evidence that serum hepatitis is contagious, the majority of reports indicating that the disease has little tendency to spread (2, 4) . The transmission of the agent of serum hepatitis by nasopharyngeal washings (37) suggests that contact infection may be possible, but this work has not yet been confirmed. The 2 cases reported by Propert (36) (2) , and in the U. S. Army (1942) (4) , suggests that the disease may be caused by a different strain of the same agent or by a different agent than that which causes the epidemic type of infective hepatitis. This distinction does not apply, however, to the sporadic form of infective hepatitis, for there is as yet no conclusive evidence that supports a differentiation of its causative agent from that of serum hepatitis.
Hepatitis without jaundice. Eppinger (29) has described several cases in which severe liver damage was found at autopsy in patients who had had no hyperbilirubinemia. For these cases, he used the term hepatitis sine ictero. Such terminal observations are quite different from the detection of hepatitis sine ictero in living subjects. Van Rooyen and Gordon (32) suspected the occurrence of hepatitis without jaundice, and Cameron (30) has stated: "other evidence from Palestine seems to show that jaundice is not essential and that a subdivision into hepatitis cum ictero and sine ictero may be justified."12 The evidence from Palestine was not given, perhaps due to wartime restrictions, so that the data presented herein apparently provide the best evidence, to date, of hepatitis sine ictero in living subjects. As cases of this type have unquestionably been overlooked, it is probable that the available statistics afford an erroneous estimate of the true incidence of hepatitis. In addition, the recognition of hepatitis without jaundice will perhaps lead to a better understanding of the course and manifestations of the disease.
Summarizing the observations in this group, the stages of serum hepatitis may be tentatively outlined as follows: 
